CVE-2017-12970

Public Exploit

Description

Cross-site request forgery (CSRF) vulnerability in Apache2Triad 1.5.4 allows remote attackers to hijack the authentication of authenticated users for requests that (1) add or (2) delete user accounts via a request to phpsftpd/users.php.

Category

8.8
CVSS
Severity: High
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.24%
Third-Party Advisory altervista.org Third-Party Advisory packetstormsecurity.com Third-Party Advisory securityfocus.com Third-Party Advisory exploit-db.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://www.exploit-db.com/exploits/42520/ exploit vdb entry third party advisory
http://hyp3rlinx.altervista.org/advisories/APACHE2TRIAD-SERVER-STACK-v1.5.4-MULTIPLE-CVE.txt third party advisory exploit
http://www.securityfocus.com/bid/100447 vdb entry third party advisory
http://packetstormsecurity.com/files/143863/Apache2Triad-1.5.4-CSRF-XSS-Session-Fixation.html exploit vdb entry third party advisory

Frequently Asked Questions

What is the severity of CVE-2017-12970?
CVE-2017-12970 has been scored as a high severity vulnerability.
How to fix CVE-2017-12970?
To fix CVE-2017-12970, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-12970 being actively exploited in the wild?
It is possible that CVE-2017-12970 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.